Axiss Aglow Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 25-06-2024
- Paid Up Capital ₹ 1.00 M
as on 25-06-2024
- Company Age 8 Year, 25 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 M
as on 25-06-2024
- Revenue %
(FY 2019)
- Profit 39.31%
(FY 2019)
- Ebitda 53.73%
(FY 2019)
- Net Worth -6.94%
(FY 2019)
- Total Assets -6.73%
(FY 2019)
About Axiss Aglow Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.00 M.
Sheela Singh and Alka Singh serve as directors at the Company.
- CIN/LLPIN
U24304UP2016PTC087960
- Company No.
087960
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Nov 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Axiss Aglow Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sheela Singh  | Director | 06-Jun-2020 | Current |
| Alka Singh | Director | 25-Nov-2016 | Current |
Financial Performance and Corporate Structure Insights of Axiss Aglow Pharma.
Axiss Aglow Pharma Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 39.31% increase in profit. The company's net worth dipped by a decrease of 6.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Axiss Aglow Pharma?
In 2019, Axiss Aglow Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Prabhanjan Tour & Travel Corporation Private LimitedActive 2 years 11 months
Sheela Singh and Alka Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Oct 2021 | ₹4.00 M | Open |
How Many Employees Work at Axiss Aglow Pharma?
Unlock and access historical data on people associated with Axiss Aglow Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Axiss Aglow Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axiss Aglow Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
